Intravitreal triamcinolone acetonide for cystoid macular edema secondary to central serous chorioretinopathy.
OBJECTIVE
To describe a patient with cystoid macular edema secondary to chronic central serous chorioretinopathy treated successfully with intravitreal triamcinolone acetonide.


METHODS
Observational case report.


RESULTS
A 66-year-old patient presented with cystoid macular edema in his right eye 10 years after initial presentation with subretinal fluid from central serous chorioretinopathy. Cystoid macular edema was found to be unresponsive to photodynamic therapy, intravitreal bevacizumab, and topical nonsteroidal antiinflammatory drops. The patient was treated with intravitreal triamcinolone acetonide with successful resolution of cystoid macular edema by clinical examination and optical coherence tomography. Best-corrected visual acuity improved from 20/70 to 20/30 after treatment.


CONCLUSIONS
Intravitreal triamcinolone acetonide was used to successfully treat cystoid macular edema secondary to chronic central serous chorioretinopathy. Treatment with local corticosteroids did not seem to worsen central serous chorioretinopathy in either the treated or fellow eye.
From the New England Eye Center, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts.
Mark E
ME
Patron
Laurel N
LN
Vuong
Jay S
JS
Duker